EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Insulin Resistance: The Increased Risk of Cancers

Leszek Szablewski

Current Oncology · 13.02.2024 · 31 (2) · 998-1027

DOI: 10.3390/curroncol31020075 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 13.02.2024. Verfasst von Leszek Szablewski. Beteiligte Einrichtung: Chair and Department of General Biology and Parasitology, Medical University of Warsaw, Chałubińskiego 5 Str., 02-004 Warsaw, Poland. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus, Type 2, Hyperinsulinism. Die Arbeit wurde bisher 113-mal zitiert (Crossref) und nennt 289 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insulin resistance, also known as impaired insulin sensitivity, is the result of a decreased reaction of insulin signaling to blood glucose levels. This state is observed when muscle cells, adipose tissue, and liver cells, improperly respond to a particular concentration of insulin. Insulin resistance and related increased plasma insulin levels (hyperinsulinemia) may cause metabolic impairments, which are pathological states observed in obesity and type 2 diabetes mellitus. Observations of cancer patients confirm that hyperinsulinemia is a major factor influencing obesity, type 2 diabetes, and cancer. Obesity and diabetes have been reported as risks of the initiation, progression, and metastasis of several cancers. However, both of the aforementioned pathologies may independently and additionally increase the cancer risk. The state of metabolic disorders observed in cancer patients is associated with poor outcomes of cancer treatment. For example, patients suffering from metabolic disorders have higher cancer recurrence rates and their overall survival is reduced. In these associations between insulin resistance and cancer risk, an overview of the various pathogenic mechanisms that play a role in the development of cancer is discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceDiabetes Mellitus, Type 2HyperinsulinismHumansNeoplasm Recurrence, LocalObesityInsulin

Stichwörter der Autor:innen

cancersinsulininsulin cellular signalinginsulin resistanceinsulin-like growth factors

Substanzen

Insulin

Autor:innen und Institutionen

  • Chair and Department of General Biology and Parasitology, Medical University of Warsaw, Chałubińskiego 5 Str., 02-004 Warsaw, Poland.

Zitieren

APA

Szablewski, L. (2024). Insulin Resistance: The Increased Risk of Cancers. Current Oncology, 31(2), 998-1027. https://doi.org/10.3390/curroncol31020075

Vancouver

Szablewski L. Insulin Resistance: The Increased Risk of Cancers. Current Oncology. 2024;31(2):998-1027. doi:10.3390/curroncol31020075

BibTeX
@article{Szablewski2024,
  author = {Szablewski, Leszek},
  title = {Insulin Resistance: The Increased Risk of Cancers},
  journal = {Current Oncology},
  year = {2024},
  volume = {31},
  number = {2},
  pages = {998--1027},
  doi = {10.3390/curroncol31020075}
}
Kostenlos starten →